Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Surprised?! Pharma Employees Worry About Jobs
Pharmalot
Tuesday, February 14, 2012 - 11:00am
tags:
layoffs
Loss Widens at Theravance, Rev Dips
Yahoo/Zacks
Tuesday, February 14, 2012 - 10:58am
tags:
earnings, Theravance
Pfizer says its drug is best hope vs. Alzheimer's
Reuters
Tuesday, February 14, 2012 - 10:57am
tags:
Pfizer, Alzheimer's disease, BIO CEO Conference, bapineuzumab, Eli Lilly, solanezumab
Watson Pharma posts higher results, ups forecast
Reuters
Tuesday, February 14, 2012 - 10:55am
tags:
Watson Pharmaceuticals, earnings
3 Healthcare Stocks For A Healthy Return
Seeking Alpha
Tuesday, February 14, 2012 - 10:54am
tags:
Abbott Laboratories, Merck, Pfizer, Boston Scientific
DNA sequencing exposes new uses for Pfizer targeted cancer drugs
Fierce Biotech
Monday, February 13, 2012 - 8:03pm
tags:
DNA sequencing, Pfizer, cancer
Regeneron climbs after raising Eylea sales outlook
Yahoo/AP
Monday, February 13, 2012 - 8:01pm
tags:
Regeneron, Eylea
Pharmacyclics Shares Popped Again: What You Need to Know
Motley Fool
Monday, February 13, 2012 - 8:00pm
tags:
Pharmacyclics
Replacing Coumadin: A $10 Billion Opportunity
Seeking Alpha
Monday, February 13, 2012 - 7:58pm
tags:
Coumadin, Eliquis, Pfizer, Apixaban, Bristol-Myers Squibb, Xarelto, Bayer, JNJ, Pradaxa, Boehringer Ingelheim
Merck gets FDA approval of drug to treat glaucoma, ocular hypertension
Yahoo/AP
Monday, February 13, 2012 - 7:55pm
tags:
FDA, Merck, glaucoma, ocular hypertension, Zioptan
German data provider accused of selling private script info
Fierce Pharma
Monday, February 13, 2012 - 12:04pm
tags:
drug data, prescription data, Germany
What Bristol-Myers Squibb Does With Its Cash
Motley Fool
Monday, February 13, 2012 - 11:59am
tags:
cash, Bristol-Myers Squibb
U.S. delays decision on Novartis's meningitis drug
Reuters
Monday, February 13, 2012 - 11:12am
tags:
Novartis, meningitis, Menveo, FDA
Pharmacists And Shire Spar Over Adderall Shortage
Pharmalot
Monday, February 13, 2012 - 11:09am
tags:
Adderall, ADHD, Shire, drug shortages
BIO CEO Conference Live Blog
TheStreet.com
Monday, February 13, 2012 - 10:30am
tags:
BIO CEO Conference, Celsion, Cyclacel, Navidea Biopharmaceuticals, Chelsea Therapeutics, Titan, Galena Biopharma, Oxigene
Here's Why Allergan's Earnings Are Worse Than They Look
Motley Fool
Monday, February 13, 2012 - 10:28am
tags:
earnings, Allergan
Valeant Pharmaceuticals to buy Eyetech
Reuters
Monday, February 13, 2012 - 10:27am
tags:
Valeant Pharmaceuticals, M&A, Eyetech
Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.
Yahoo
Monday, February 13, 2012 - 10:26am
tags:
Inhibitex, Bristol-Myers Squibb, M&A
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Monday, February 13, 2012 - 10:25am
tags:
Vertex, hepatitis C, Gilead
Expecting Gilead To Break $70, Outperforming Merck
Seeking Alpha
Sunday, February 12, 2012 - 11:57am
tags:
Gilead Sciences, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.